Briefly, pDCs, which in humans express the markers BDCA-2 (CD303) and CD123, can produce large amounts of type I interferons (IFNs) which are important for the generation of immune responses against tumor cells and viruses (35). This evidence concerns the gene CLEC4C and neoplasm.